Lonza said it will be investing CHF 5.8 million in a formulation plant for its Meta metaldehyde in Visp, Switzerland. The company said the plant will enable it to supply its own formulations, allowing Lonza to serve the market with metaldehyde as an active substance, as well as with ready-made slug pellets.
The plant is expected to come online in the second half of 2012.
Valerie Diele-Braun resigned from her position as CEO and member of the Executive Board of IMCD at the end of April for personal reasons.
Oxea is returning to its old name and its roots.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
Novo Nordisk recently announced changes to its executive leadership and Board of Directors.
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.
